Mitsubishi UFJ Morgan Stanley Securities’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$78K Sell
65
-144
-69% -$147K 0.24% 67
2026
Q1
$192K Sell
209
-87
-29% -$88.2K 0.47% 59
2025
Q4
$318K Buy
+296
New +$283K 0.5% 44
2024
Q1
Sell
-1,175
Closed -$685K 38
2023
Q4
$685K Buy
+1,175
New +$686K 3.95% 10
2023
Q3
Sell
-154
Closed -$72.2K 32
2023
Q2
$72.2K Buy
+154
New +$64.6K 0.42% 14
2023
Q1
Sell
-60
Closed -$22K 119
2022
Q4
$22K Sell
60
-70
-54% -$24.8K 0.19% 67
2022
Q3
$42K Hold
130
0.57% 27
2022
Q2
$42K Hold
130
0.06% 29
2022
Q1
$37K Sell
130
-60
-32% -$15.4K 0.03% 44
2021
Q4
$52K Sell
190
-190
-50% -$48.2K 0.03% 89
2021
Q3
$88K Buy
+380
New +$93.8K 0.08% 39

Other funds holding LLY

Mitsubishi UFJ Morgan Stanley Securities's LLY Position: Q2 2026 in Review

Mitsubishi UFJ Morgan Stanley Securities reduced its Eli Lilly (LLY) stake by 69% in Q2 2026, selling an estimated $147K and leaving 65 shares worth $78K. The position accounts for 0.24% of the portfolio, ranked #67.

Mitsubishi UFJ Morgan Stanley Securities first reported a position in LLY in Q3 2021 and has held it in 11 quarters since. The position peaked at $685K in Q4 2023. 2,043 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Mitsubishi UFJ Morgan Stanley Securities held 65 shares of Eli Lilly worth $78K as of Q2 2026.
  • Mitsubishi UFJ Morgan Stanley Securities sold 144 Eli Lilly shares in Q2 2026, an estimated $147K.
  • Eli Lilly made up 0.24% of Mitsubishi UFJ Morgan Stanley Securities's portfolio in Q2 2026, its #67 holding.
  • Mitsubishi UFJ Morgan Stanley Securities first reported a position in Eli Lilly in Q3 2021 and has held it in 11 quarters since.
  • Mitsubishi UFJ Morgan Stanley Securities's Eli Lilly position peaked at $685K in Q4 2023.
  • 2,043 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Mitsubishi UFJ Morgan Stanley Securities's 13F filing for Q2 2026, filed 15 Jul 2026.